Current Report Filing (8-k)
September 12 2022 - 07:01AM
Edgar (US Regulatory)
0001764046 false 00-0000000 0001764046
2022-09-09 2022-09-09 0001764046 us-gaap:CommonStockMember
2022-09-09 2022-09-09 0001764046
us-gaap:SeriesAPreferredStockMember 2022-09-09 2022-09-09
iso4217:USD xbrli:shares iso4217:USD xbrli:shares
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, DC
20549
FORM
8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of
1934
Date of report (date of earliest event reported): September
12, 2022 (September
9, 2022)
CLARIVATE PLC
(Exact name of registrant as specified in its charter)
Jersey, Channel Islands
(State or other jurisdiction of incorporation)
001-38911
(Commission File Number)
N/A
(IRS Employer Identification
No.)
30 St. Mary Axe
London EC3A 8BE
United Kingdom
(Address of principal executive offices)
Not applicable
(Zip Code)
(44)207
433 4000
Registrant’s telephone number, including area code
Check the appropriate box below if the Form 8-K filing is intended
to simultaneously satisfy the filing obligation of the registrant
under any of the following provisions:
¨ |
Written communications pursuant to
Rule 425 under the Securities Act (17 CFR 230.425) |
¨ |
Soliciting material pursuant to Rule
14a-12 under the Exchange Act (17 CFR 240.14a-12) |
¨ |
Pre-commencement communications
pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR
240.14d-2(b)) |
¨ |
Pre-commencement communications
pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR
240.13e-4(c)) |
Securities registered pursuant to Section 12(b) of the Securities
Exchange Act of 1934:
Title of Each Class |
Trading Symbol |
Name of Each Exchange on Which
Registered |
Ordinary shares, no par value |
CLVT |
New York Stock Exchange |
5.25% Series A Mandatory Convertible Preferred Shares, no par
value |
CLVT PR A |
New York Stock Exchange |
Indicate by check mark whether the registrant is an emerging growth
company as defined in Rule 405 of the Securities Act of 1933
(§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange
Act of 1934 (§240.12b-2 of this chapter).
Emerging growth company
¨
If an emerging growth company,
indicate by check mark if the registrant has elected not to use the
extended transition period for complying with any new or revised
financial accounting standards provided pursuant to Section 13(a)
of the Exchange Act. ¨
Item 7.01. |
Regulation FD
Disclosure. |
On September 12, 2022, Clarivate Plc
(the “Company” or “Clarivate”) issued
a press release announcing the transaction described
under Item 8.01 below, which is furnished as Exhibit 99.1
hereto and shall not be deemed “filed” for purposes of Section 18
of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), and shall not be
incorporated by reference into any registration statement or other document pursuant
to the Securities Act of 1933, as amended, or the Exchange Act,
except as otherwise expressly stated in such filing.
On September 9, 2022, Camelot UK Bidco
Limited, a wholly owned indirect subsidiary of the Company, entered
into a definitive agreement with Newfold Digital, Inc. (the
“Buyer”) to sell the Company’s MarkMonitor domain management
business to the Buyer for an aggregate purchase price of
approximately $302.5 million. The agreement contemplates
delayed closings in China and Japan pending completion of certain
country-specific closing conditions.
Of the purchase price, $292.5 million will be payable at the
initial closing, subject to certain adjustments, and $10 million
will be payable upon the completion of all deferred closings. The
initial closing is expected to occur in the fourth quarter of
2022, subject to the receipt of required regulatory
approvals and the satisfaction of other customary closing
conditions.
Forward-Looking Statements
This report contains “forward-looking statements” as defined in the
Private Securities Litigation Reform Act of 1995. Forward-looking
statements are neither historical facts nor assurances of future
performance. Instead, they are based only on management’s current
beliefs, expectations, and assumptions regarding our ability to
close the transaction and to realize the expected synergies of the
transaction, as well as the future of our business, future plans
and strategies, projections, anticipated events and trends, the
economy, and other future conditions. Because forward-looking
statements relate to the future, they are difficult to predict and
many are outside of our control. Important factors that could cause
our actual results and financial condition to differ materially
from those indicated in the forward-looking statements are
discussed under the caption “Risk Factors” in our 2021 Annual
Report on Form 10-K, along with our other filings with the
Securities and Exchange Commission (“SEC”). However, those factors
should not be considered to be a complete statement of all
potential risks and uncertainties. Additional risks and
uncertainties not known to us or that we currently deem immaterial
may also impair our business operations. Forward-looking statements
are based only on information currently available to our management
and speak only as of the date of this report. We do not assume any
obligation to publicly provide revisions or updates to any
forward-looking statements, whether as a result of new information,
future developments or otherwise, should circumstances change,
except as otherwise required by securities and other applicable
laws. Please consult our public filings with the SEC or our website
at www.clarivate.com.
Item 9.01. |
Financial Statements and
Exhibits. |
(d) Exhibits
SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of
1934, the registrant has duly caused this report to be signed on
its behalf by the undersigned, thereunto duly authorized.
|
CLARIVATE
PLC |
|
|
Date:
September 12, 2022 |
By: |
/s/ Jonathan
Collins |
|
Name: |
Jonathan Collins |
|
Title: |
Executive Vice President and
Chief Financial Officer |
Clarivate (NYSE:CLVT)
Historical Stock Chart
From Dec 2022 to Jan 2023
Clarivate (NYSE:CLVT)
Historical Stock Chart
From Jan 2022 to Jan 2023